强化管理干预对慢性心力衰竭患者治疗依从性、心功能、生活质量及预后的影响

摘要

目的：探讨强化管理干预对慢性心力衰竭患者治疗依从性、心功能、生活质量及预后的影响。方法选择2013年9月~2014年9月入住大庆油田总医院心内科的充血性心力衰竭患者100例作为观察对象，随机分为强化管理干预组50例和常规管理干预组50例，比较两组患者的治疗依从性及两组患者治疗前后心功能各项指标、生活质量及预后情况。结果强化管理干预组其完全依从率达84%，显著高于常规管理干预组（P<0.05）。强化管理干预组的HR、LVEF、CO及E/A较常规管理干预组显著改善，其生活质量各项评分也较常规管理干预组显著改善（P<0.05）。且强化管理干预组再次住院率16.0%，显著低于常规管理干预组（P<0.05）。强化管理干预组的病死率2.0%，略低于常规管理干预组。结论对慢性充血性心力衰竭患者实施强化管理，可以提高其治疗依从性，明显改善心衰患者心功能及预后，提高心衰患者的生活质量。%Objective To investigate the effect of strengthening intervention management on the compliance, heart func-tion, life quality and prognosis for the patients with chronic heart failure. Methods From September 2013 to September 2014, 100 cases admitted to the Department of Cardiology of General Hospital of Daqing Oil Field in patients with congestive heart failure were selected as the observation objects, they were randomly divided into strengthening the management of intervention group 50 cases and routine management of the intervention group 50 cases, treatment com-pliance and cardiac function index, life quality and prognosis the situation of the patients before and after treatment were compared between the two groups. Results The complete compliance rate of strengthen the management of inter-vention group was 84%, significantly higher than that of the conventional management intervention group (P<0.05). HR, LVEF, CO and E/A of strengthen the management of intervention group significantly improved than the control group, the quality of life scores also improved significantly compared with the conventional management intervention group (P<0.05). And rehospitalization rate of strengthen the management of intervention group was 16.0%, significantly lower than that of the conventional management intervention group, and the mortality rate of strengthen the management of intervention group was 2.0%, was slightly lower than the conventional management intervention group. Conclusion The implementation of strengthening the management of patients with chronic congestive heart failure, can improve the treatment compliance, significantly improve cardiac function and prognosis in patients with heart failure, improve the quality of life of patients with heart failure.